An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray

[1]  Yanbin Jia,et al.  Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders , 2004, Molecular Psychiatry.

[2]  Marylyn D Ritchie,et al.  Renin-Angiotensin System Gene Polymorphisms and Atrial Fibrillation , 2004, Circulation.

[3]  J. H. Moore,et al.  Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus , 2004, Diabetologia.

[4]  Jason H. Moore,et al.  The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases , 2003, Human Heredity.

[5]  J. Kennedy,et al.  N‐methyl‐d‐aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case‐control analyses , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  F. Fumagalli,et al.  Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia , 2003, Biological Psychiatry.

[7]  Jason H. Moore,et al.  Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions , 2003, Bioinform..

[8]  Jason H. Moore,et al.  Power of multifactor dimensionality reduction for detecting gene‐gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity , 2003, Genetic epidemiology.

[9]  Cristina Battaglia,et al.  Detection of HLA polymorphisms by ligase detection reaction and a universal array format: a pilot study for low resolution genotyping. , 2003, Human immunology.

[10]  C. Hung,et al.  Systematic mutation analysis of the human glutamate receptor, ionotropic, N-methyl-D-aspartate 1 gene(GRIN1) in schizophrenic patients , 2002, Psychiatric genetics.

[11]  Y. Fukumaki,et al.  Polymorphism analysis of the upstream region of the human N-methyl-d-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia , 2002, Schizophrenia Research.

[12]  Minerva M. Carrasquillo,et al.  Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease , 2002, Nature Genetics.

[13]  Cristina Battaglia,et al.  Bacterial discrimination by means of a universal array approach mediated by LDR (ligase detection reaction) , 2002, BMC Microbiology.

[14]  Scott M. Williams,et al.  New strategies for identifying gene-gene interactions in hypertension , 2002, Annals of medicine.

[15]  N. Williams,et al.  Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor , 2002, Molecular Psychiatry.

[16]  J. H. Moore,et al.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.

[17]  D. B. Berman,et al.  Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients , 2001, Molecular Psychiatry.

[18]  H. Ropers,et al.  Detection of mitochondrial single nucleotide polymorphisms using a primer elongation reaction on oligonucleotide microarrays. , 2001, Nucleic acids research.

[19]  T. Arinami,et al.  Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia , 2001, Molecular Psychiatry.

[20]  T. Arinami,et al.  Mutation analysis of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia , 2000, Neuroscience Letters.

[21]  L. Jorde,et al.  Linkage disequilibrium and the search for complex disease genes. , 2000, Genome research.

[22]  Francis Barany,et al.  Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2 , 2000, Nature Biotechnology.

[23]  N. Gerry,et al.  Universal DNA microarray method for multiplex detection of low abundance point mutations. , 1999, Journal of molecular biology.

[24]  J. Hoheisel,et al.  Versatile derivatisation of solid support media for covalent bonding on DNA-microchips. , 1999, Nucleic acids research.

[25]  K. Gunderson,et al.  Mutation detection by ligation to complete n-mer DNA arrays. , 1998, Genome research.

[26]  J. Krystal,et al.  The NMDA antagonist model for schizophrenia: promise and pitfalls. , 1998, Pharmacopsychiatry.

[27]  P. V. Rayudu,et al.  Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A , 1998, Nature.

[28]  L. Thibault,et al.  Dynamic mechanical deformation of neurons triggers an acute calcium response and cell injury involving the N‐methyl‐D‐aspartate glutamate receptor , 1998, Journal of neuroscience research.

[29]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[30]  L Peltonen,et al.  Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. , 1997, Genome research.

[31]  S. Tonegawa,et al.  Modification of NMDA Receptor Channels and Synaptic Transmission by Targeted Disruption of the NR2C Gene , 1996, The Journal of Neuroscience.

[32]  Masahiko Watanabe,et al.  Impairment of Suckling Response, Trigeminal Neuronal Pattern Formation, and Hippocampal LTD in NMDA Receptor ε2 Subunit Mutant Mice , 1996, Neuron.

[33]  T. Yagi,et al.  Reduced spontaneous activity of mice defective in the ε4 subunit of the NMDA receptor channel , 1995 .

[34]  G. Ellison.  The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias , 1995, Brain Research Reviews.

[35]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit , 1995, Nature.

[36]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.

[37]  T. Yagi,et al.  Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. , 1995, Nature.

[38]  T. Yagi,et al.  Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel. , 1995, Brain research. Molecular brain research.

[39]  J. Connor,et al.  Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death , 1994, Neuron.

[40]  Susumu Tonegawa,et al.  Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice , 1994, Cell.

[41]  S. Nakanishi,et al.  Molecular diversity and functions of glutamate receptors. , 1994, Annual review of biophysics and biomolecular structure.

[42]  S. Heinemann,et al.  Cloned glutamate receptors. , 1994, Annual review of neuroscience.

[43]  A. Thiel,et al.  Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. , 1994, Nucleic acids research.

[44]  E. Southern,et al.  Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides: evaluation using experimental models. , 1992, Genomics.

[45]  S. Nakanishi,et al.  Molecular cloning and characterization of the rat NMDA receptor , 1991, Nature.

[46]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[47]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.